Evidence mapPaperPMID 24334174Full record

ArticleCirculation2014

Sodium glucose transport 2 (SGLT2) inhibition decreases glomerular hyperfiltration: is there a role for SGLT2 inhibitors in diabetic kidney disease?

Robert C Stanton

2 registry-linked trialsAbstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Circulation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02911792 phase4completedstarted 2016, after this paper: background citation

Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration

Ran2016Enrolled72Registered outcomes1Posted comparisons0ConditionsDiabetes Mellitus, Type 2Armsdapagliflozin, Glipizide 5 MG, Metformin
Open the trial in the graph
NCT02964585 phase4completedstarted 2016, after this paper: background citation

Role of Canagliflozin on Gene Expression and Function of CD34+ Endothelial Progenitor Cells and Renal Function in Patients With Type 2 Diabetes

Ran2016Enrolled34Registered outcomes18Posted comparisons0ConditionsType 2 Diabetes MellitusArmsCanagliflozin, Placebo
Open the trial in the graph
3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. SGLT2 Inhibitors for Cardioprotection.Oman medical journal · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Human Glucose Transporters in Renal Glucose Homeostasis.International journal of molecular sciences · 2021
    Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Diabetic nephropathy: newer therapeutic perspectives.Journal of community hospital internal medicine perspectives · 2018
    Review
  17. Distribution of glucose transporters in renal diseases.Journal of biomedical science · 2017
    Review
  18. Review
  19. Article
  20. Beat it early: putative renoprotective haemodynamic effects of oral hypoglycaemic agents.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2016
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Robert C StantonJoslin Diabetes Center, Boston, MA; Beth Israel Deaconess Medical Center, Boston, MA; and Harvard Medical School, Boston, MA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Sodium-Glucose Transporter 2 InhibitorsBenzhydryl CompoundsDiabetes Mellitus, Type 1FemaleGlomerular Filtration RateGlucosidesHemodynamicsHumansKidneyMaleSodium-Glucose Transporter 2Benzhydryl CompoundsempagliflozinGlucosidesSodium-Glucose Transporter 2Sodium-Glucose Transporter 2 Inhibitorsdiabetes mellitusEditorialskidneysodium glucose cotransporters

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.